Rakesh Pandey
Business Register and Tax Board debtor list as of 04.10.2026. Current roles. This is a fact, not an assessment of the person.
On boards
3
| Company and role | Since | Revenue |
|---|---|---|
| AS Bravo PharmaceuticalsBoard member | 29.11.2016 | 28 873 € BBB |
| AS Bravo Healthcare tax debtBoard member | 04.04.2018 | 24 528 € C |
| Competence Centre for Cancer Research AS tax debtBoard member | 08.11.2017 | 5 000 € C |
Sorted by revenue. Revenue: latest annual report or last 4 quarters (Tax Board).
Tegelik kasusaaja
4
| Company | Since | Revenue |
|---|---|---|
| AS Bravo Pharmaceuticals | 11.08.2019 | 28 873 € BBB |
| AS Bravo Healthcare | 29.10.2018 | 24 528 € C |
| Competence Centre for Cancer Research AS | 05.05.2021 | 5 000 € C |
| Bravo Diagnostics OÜ | 24.10.2018 | 0 € |
The person who ultimately owns or controls the company
Osalused ettevõtetes
1
| Ettevõte ja osalus | Since | Revenue |
|---|---|---|
| Bravo Diagnostics OÜosalus 20,0% | 02.09.2023 | 0 € |
Related persons
3
Nasdaq CSD SE 46,14 bn €AS Bravo Pharmaceuticals, AS Bravo Healthcare, Competence Centre for Cancer Research ASTaavi Kikas 539 k €Bravo Diagnostics OÜReena Singh 33 873 €AS Bravo Pharmaceuticals
Persons on the same company boards. The amount is the combined revenue of their companies; largest first.
Business Register open data. Only current roles are shown. Personal ID codes are not shown. Privacy · Data corrections and objections